Health Condition 1: J452- Mild intermittent asthma
Conditions
Interventions
None listed
Sponsors
Dr Amit Dattatraya Mundhe
Eligibility
Inclusion criteria
Inclusion criteria: Children having Bronchospasm. Children with mild to moderate dyspnea. Patients with recurrent episodes of wheezing, breathlessness, and cough, especially with seasonal or allergen exposure
Exclusion criteria
Exclusion criteria: Bronchospasm falling into any category of anaphylaxis. Patients with severe or acute exacerbation of asthma requiring emergency intervention and ICU admission. Presence of concomitant debilitating systemic illnesses such as tuberculosis, congenital heart disease or congenital respiratory tract anomalies. Children with co-morbidities such as diabetes, seizure disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to be equal or improvement by 25 % will be seen in parameters such as Ghurghuraka shabda (wheezing), Kasa (cough), Swarabheda (hoarseness), and Pratishyaya (rhinitis). Relief in Swarabheda (Hoarseness) : It is expected to see improvement in swarabheda which is generally not observed with conventional therapy. Timepoint: Baseline and 2 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in School Absenteeism: With effective symptom management and fewer exacerbations, a reduction in school absentee days is anticipated, supporting better quality of life and academic performance. No Adverse reactions on long term use: The intervention is expected to show no significant adverse effects even with repeated or long-term use, ensuring better safety and tolerability compared to corticosteroids. Timepoint: Baseline and 7 days | — |
Countries
India
Contacts
Public ContactDrRahul H Gujarathi
Bharati Vidyapeeth Deemed to be University
Outcome results
None listed